Showing results (1091-1100 of 2,063) with videos related to

Sort By:
Pageof 207
Brachytherapy|December 3, 2016
Avoidance of late rectal toxicity after high-dose-rate brachytherapy boost treatment for prostate cancerBorut Kragelj, Jernej Zlatic, Lijana Zaletel-Kragelj
Brachytherapy|December 3, 2016
Skin surface brachytherapy: A survey of contemporary practice patternsAnna O Likhacheva, Phillip M Devlin, Shervin M Shirvani, et al.
Brachytherapy|October 11, 2016
Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancerAnnette M Ilg, Aaron A Laviana, Mitchell Kamrava, et al.
Brachytherapy|October 11, 2016
Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapyTyler P Robin, Arya Amini, Tracey E Schefter, et al.
Brachytherapy|October 11, 2016
A novel conformal superficial high-dose-rate brachytherapy device for the treatment of nonmelanoma skin cancer and keloidsClara Ferreira, Daniel Johnson, Karl Rasmussen, et al.
Brachytherapy|October 11, 2016
Predictive factors of rectal toxicity after permanent iodine-125 seed implantation: Prospective cohort study in 2339 patientsNorihisa Katayama, Atsunori Yorozu, Shinichiro Maruo, et al.
Brachytherapy|April 3, 2017
Clinical transition to model-based dose calculation algorithm: A retrospective analysis of high-dose-rate tandem and ring brachytherapy of the cervixDayee Jacob, Melissa Lamberto, Lana DeSouza Lawrence, et al.
Brachytherapy|April 3, 2017
Perianal synovial sarcoma treated postoperatively with Iodine-125 brachytherapy: Technical detailsSusan Tovey, Clare Stannard, Gerrie Maree, et al.
Brachytherapy|December 27, 2016
Decline in acute urinary toxicities with increased institutional experience: 15-year experience of permanent seed prostate brachytherapy in a single Australasian institutionWee Loon Ong, Bronwyn Matheson, Jeremy Millar
Brachytherapy|March 25, 2017
Trends in cervical cancer brachytherapy volume suggest case volume is not the primary driver of poor compliance rates with brachytherapy delivery for locally advanced cervical cancerDaniel M Trifiletti, Surbhi Grover, Bruce Libby, et al.
Pageof 207